Stakeholders' opinions and expectations of the Global Fund and their potential economic implications.
OBJECTIVE
To analyse stakeholder opinions and expectations of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, and to discuss their potential economic and financial implications.


METHODS
The Global Fund commissioned an independent study, the '360 degrees Stakeholder Survey', to canvas feedback on the organization's reputation and performance with an on-line survey of 909 respondents representing major stakeholders worldwide. We created a proxy for expectations based on categorical responses for specific Global Fund attributes' importance to the stakeholders and current perceived performance.


METHODS
Using multivariate regression, we analysed 23 unfulfilled expectations related to: resource mobilization; impact measurement; harmonization and inclusion; effectiveness of the Global Fund partner environment; and portfolio characteristics. The independent variables are personal and regional-level characteristics that affect expectations.


RESULTS
The largest unfulfilled expectations relate to: mobilization of private sector resources; efficiency in disbursing funds; and assurance that people affected by the three diseases are reached. Stakeholders involved with the fund through the country coordinating mechanisms, those working in multilateral organizations and persons living with HIV are more likely to have unfulfilled expectations. In contrast, higher levels of involvement with the fund correlate with fulfilled expectations. Stakeholders living in sub-Saharan Africa were less likely to have their expectations met.


CONCLUSIONS
Stakeholders' unfulfilled expectations result largely from factors external to them, but also from factors over which they have influence. In particular, attributes related to partnership score poorly even though stakeholders have influence in that area. Joint efforts to address perceived performance gaps may improve future performance and positively influence investment levels and economic viability.
Galárraga
Omar
O
Center for Evaluation Research and Surveys, National Institute of Public Health (INSP)/Mexican School of Public Health, Cuernavaca, Mexico.
Bertozzi
Stefano M
SM
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control / Q000628:therapy; D001290:Attitude; D003906:Developing Countries; D005376:Financial Management / Q000458:organization & administration*; D005378:Financial Support; D005381:Financing, Organized; D014943:Global Health; D006801:Humans; D007391:International Cooperation; D008288:Malaria / Q000517:prevention & control / Q000628:therapy; D015999:Multivariate Analysis; D012044:Regression Analysis; D014376:Tuberculosis / Q000517:prevention & control / Q000628:therapy